LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 2 | J12 | 72 | hr | 1235 | 4665 | 4277 | 1.0906 | 1.0993 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 3 | J12 | 72 | hr | 1235 | 4797 | 4583 | 1.0466 | 1.0488 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 1 | J11 | 72 | hr | 1235 | 4765 | 4355 | 1.0939 | 1.1013 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 2 | J11 | 72 | hr | 1235 | 4658 | 4277 | 1.0890 | 1.0975 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 3 | J11 | 72 | hr | 1235 | 4741 | 4583 | 1.0344 | 1.0361 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 1 | J10 | 72 | hr | 1235 | 4544 | 4355 | 1.0432 | 1.0471 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 2 | J10 | 72 | hr | 1235 | 4682 | 4277 | 1.0946 | 1.1035 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 3 | J10 | 72 | hr | 1235 | 4775 | 4583 | 1.0418 | 1.0438 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 1 | J09 | 72 | hr | 1235 | 4795 | 4355 | 1.1008 | 1.1085 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 2 | J09 | 72 | hr | 1235 | 4869 | 4277 | 1.1383 | 1.1500 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 3 | J09 | 72 | hr | 1235 | 5007 | 4583 | 1.0924 | 1.0957 |
MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 1 | J08 | 72 | hr | 1235 | 4772 | 4355 | 1.0955 | 1.1030 |
MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 2 | J08 | 72 | hr | 1235 | 4683 | 4277 | 1.0948 | 1.1038 |
MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 3 | J08 | 72 | hr | 1235 | 4684 | 4583 | 1.0220 | 1.0231 |
MDA-MB-231 | Linifanib | 10 | uM | LJP6 | 1 | J07 | 72 | hr | 1235 | 1031 | 4355 | 0.2367 | -0.0950 |
MDA-MB-231 | Linifanib | 10 | uM | LJP6 | 2 | J07 | 72 | hr | 1235 | 962 | 4277 | 0.2249 | -0.1306 |
MDA-MB-231 | Linifanib | 10 | uM | LJP6 | 3 | J07 | 72 | hr | 1235 | 916 | 4583 | 0.1999 | -0.1465 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 1 | K18 | 72 | hr | 1235 | 4105 | 4474 | 0.9174 | 0.9092 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 2 | K18 | 72 | hr | 1235 | 4326 | 4578 | 0.9448 | 0.9408 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 3 | K18 | 72 | hr | 1235 | 4903 | 4929 | 0.9947 | 0.9947 |
MDA-MB-231 | PIK-93 | 0.12 | uM | LJP5 | 1 | K17 | 72 | hr | 1235 | 3962 | 4474 | 0.8854 | 0.8731 |
MDA-MB-231 | PIK-93 | 0.12 | uM | LJP5 | 2 | K17 | 72 | hr | 1235 | 4424 | 4578 | 0.9662 | 0.9640 |
MDA-MB-231 | PIK-93 | 0.12 | uM | LJP5 | 3 | K17 | 72 | hr | 1235 | 4895 | 4929 | 0.9930 | 0.9930 |
MDA-MB-231 | PIK-93 | 0.37 | uM | LJP5 | 1 | K16 | 72 | hr | 1235 | 3579 | 4474 | 0.7998 | 0.7733 |
MDA-MB-231 | PIK-93 | 0.37 | uM | LJP5 | 2 | K16 | 72 | hr | 1235 | 4159 | 4578 | 0.9084 | 0.9008 |